NCT00349713View on ClinicalTrials.gov

FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2006

Conditions
MalariaPlasmodium Falciparum Malaria
Interventions
BIOLOGICAL

FMP2.1/AS02A

FMP2.1 in GSK Biologicals' AS02A

BIOLOGICAL

Rabies vaccine (RabAvert)

RabAvert Rabies vaccine

Trial Locations (1)

Unknown

University of Bamako, Malaria Research and Training Center, Bamako

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

University of Maryland

OTHER

lead

U.S. Army Medical Research and Development Command

FED